Company intelligence / Profile preview
OPKO Renal
Miami, Florida, United Statesrayaldee.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
OPKO Renal is a specialized division of OPKO Health focused on developing and commercializing products for the treatment and management of endocrine and metabolic disorders, specifically targeting chronic kidney disease (CKD). The division's flagship product is Rayaldee (calcifediol), an extended-release formulation designed to treat secondary hyperparathyroidism in adults with stage 3 or 4 CKD and low vitamin D levels. OPKO Renal was significantly expanded through the acquisition of Cytochroma in 2013, which provided the core technology for its renal pipeline. The company continues to explore expanded indications for its vitamin D analogs, including applications for patients with stage 5 CKD on dialysis.
- Therapeutic areas
- EndocrinologyNephrology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Vifor Fresenius Medical Care Renal PharmaNicoya Lifesciences
Beyond the preview
Go deeper on OPKO Renal.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OPKO Renal.